• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    argenx SE - American Depositary Shares (NQ:ARGX)

    805.99 -16.14 (-1.96%)
    Streaming Delayed Price Updated: 11:53 AM EDT, May 15, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 134,476
    Open 819.82
    Bid (Size) 806.25 (40)
    Ask (Size) 808.00 (40)
    Prev. Close 822.13
    Today's Range 803.14 - 820.33
    52wk Range 510.06 - 934.62
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    2 Ways to Play the Big Pharma Patent Cliff ↗
    With hundreds of billions in sales on the line for drugs that will lose their patent exclusivity in the coming years, two biotech ETFs can help capitalize. 
    Via MarketBeat
    Topics ETFs Intellectual Property
    News headline image
    argenx Announces U.S. FDA Approval Expanding VYVGART and VYVGART Hytrulo for Use in All Adult Patients Living with gMG
    From argenx SE
    Via GlobeNewswire

    Performance

    YTD
    -4.0%
    -4.0%
    1 Month
    -2.7%
    -2.7%
    3 Month
    -3.3%
    -3.3%
    6 Month
    -9.6%
    -9.6%
    1 Year
    +51.4%
    +51.4%

    More News

    Read More
    News headline image
    argenx Reports First Quarter 2026 Financial Results and Provides Business Update
    From argenx SE
    Via GlobeNewswire
    News headline image
    argenx to Present at BofA Securities 2026 Health Care Conference
    From argenx SE
    Via GlobeNewswire
    News headline image
    argenx Announces Results of Annual General Meeting and Board of Directors’ Appointment of Karen Massey as Chief Executive Officer
    From argenx SE
    Via GlobeNewswire
    News headline image
    argenx to Report First Quarter 2026 Financial Results and Business Update on May 7, 2026
    From argenx SE
    Via GlobeNewswire
    News headline image
    argenx Brings Neuromuscular Leadership to AAN 2026 with New Data Supporting Broader VYVGART Use Across MG and CIDP
    From argenx SE
    Via GlobeNewswire
    News headline image
    This New $193 Million Bet Targets a Biotech With $689 Million in Revenue and a Potential Turnaround Story ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    This $116 Million Buy Joins a 360% Stock Run and Seemingly Signals Conviction in a Key Drug Launch ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    argenx announces Annual General Meeting of Shareholders on May 6, 2026
    From argenx SE
    Via GlobeNewswire
    News headline image
    This Specialized Heart Monitor Maker Just Caught the Eye of a Major Healthcare Fund ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Complementing the Future: A Deep Dive into Dianthus Therapeutics (DNTH) After Its Phase 3 Breakthrough
    Via Finterra
    Topics Economy
    News headline image
    DNTH Stock Soars After Early ‘Go’ Decision For Drug In Autoimmune Disorder Program, Boosting Wall Street Optimism For Potential Launch ↗
    Via Stocktwits
    News headline image
    argenx to Present New Data at 2026 AAN Annual Meeting that Continue to Transform Patient Outcomes in MG and CIDP and Build Upon Strength of Pipeline
    From argenx SE
    Via GlobeNewswire
    News headline image
    Argenx (ARGX) 2026 Feature: The Anatomy of a Biotech Powerhouse Transitioning to Profitability
    Via Finterra
    Topics Earnings Economy Intellectual Property
    News headline image
    argenx Reports Full Year 2025 Financial Results and Provides Fourth Quarter Business Update
    From argenx SE
    Via GlobeNewswire
    News headline image
    argenx Announces Positive Topline Results from Phase 3 ADAPT OCULUS Trial of VYVGART in Ocular Myasthenia Gravis
    From argenx SE
    Via GlobeNewswire
    News headline image
    argenx to Present at TD Cowen 46th Annual Healthcare Conference
    From argenx SE
    Via GlobeNewswire
    News headline image
    argenx to Report Full Year 2025 Financial Results and Fourth Quarter Business Update on February 26, 2026
    From argenx SE
    Via GlobeNewswire
    News headline image
    Agios Stock Down 16% in a Year as Fund Cuts Stake by $5.6 Million After 50% November Crash ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Cogent Biosciences Stock Soars 346% in a Year, but One Fund Just Sold Off $4.5 Million ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Structure Therapeutics Stock Up 187% in One Year as Fund Trims $8 Million From Stake ↗
    Via The Motley Fool
    News headline image
    Kymera Therapeutics Stock Up 120% in 1 Year as Fund Adds $3 Million More ↗
    Via The Motley Fool
    News headline image
    Roivant Sciences (ROIV): Anatomy of a 15% Surge and the Future of the ‘Vant’ Model
    Via Finterra
    Topics ETFs Economy Initial Public Offering
    News headline image
    argenx Announces FDA Acceptance of Supplemental Biologics License Application with Priority Review for VYVGART in AChR-Ab Seronegative gMG
    From argenx SE
    Via GlobeNewswire

    Frequently Asked Questions

    Is argenx SE - American Depositary Shares publicly traded?
    Yes, argenx SE - American Depositary Shares is publicly traded.
    What exchange does argenx SE - American Depositary Shares trade on?
    argenx SE - American Depositary Shares trades on the Nasdaq Stock Market
    What is the ticker symbol for argenx SE - American Depositary Shares?
    The ticker symbol for argenx SE - American Depositary Shares is ARGX on the Nasdaq Stock Market
    What is the current price of argenx SE - American Depositary Shares?
    The current price of argenx SE - American Depositary Shares is 805.99
    When was argenx SE - American Depositary Shares last traded?
    The last trade of argenx SE - American Depositary Shares was at 05/15/26 11:53 AM ET
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.